Efficacy/Safety of Low-/High-Dose Perampanel as First Adjunctive Therapy in Patients With Focal-Onset Seizures: Post Hoc Analysis of the FAME Study

被引：0

作者：

Seo, Dae Won ^{[1
]}

Lee, JiWoong ^{[2
]}

Dash, Amitabh ^{[3
]}

Lee, Sang Kun ^{[4
]}

Lee, Sang-Ahm ^{[5
]}

Malhotra, Manoj ^{[6
]}

机构：

[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea

[2] Eisai Korea Inc, Seoul, South Korea

[3] Eisai Singapore Pte Ltd, Singapore, Singapore

[4] Seoul Natl Univ Hosp, Seoul, South Korea

[5] Univ Ulsan, Coll Med, Asan Med Ctr, Seoul, South Korea

[6] Eisai Inc, Woodcliff Lake, NJ USA

来源：

EPILEPSIA | 2021年 / 62卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

201

引用

页码：51 / 51

页数：1

共 50 条

[31] Safety and effectiveness of perampanel monotherapy after adjunctive therapy through retention rate in subjects with focal-onset seizures with or without focal to bilateral tonic-clonic seizures: A multicenter retrospective study in Korea
Lim, Sung Chul
Lee, Won Gu
Kim, Dong Wook
Kim, Kwang Ki
Shon, Young -Min
Park, Jihyun
Lee, Yoona
Seo, Dae-Won
EPILEPSY & BEHAVIOR, 2023, 145
[32] Long-term efficacy and safety of adjunctive perampanel in patients from the Asia-Pacific region with refractory focal-onset seizures in Study 335 open-label extension
Nishida, Takuji
Lee, Sang Kun
Inoue, Yushi
Saeki, Kazunori
Ishikawa, Kohei
Malhotra, Manoj
Patten, Anna
Kaneko, Sunao
EPILEPSIA OPEN, 2024, 9 (02) : 501 - 512
[33] Study 603: analysis of effectiveness and safety of perampanel in a multicentre, retrospective study in patients from Korea with focal-onset seizures who converted to monotherapy
Lim, S. C.
Lee, W. G.
Kim, D. W.
Kim, K. K.
Shon, Y-M
Park, J.
Lee, Y.
Seo, D-W
EPILEPSIA, 2023, 64 : 271 - 272
[34] A phase IV, prospective, post-approval study of adjunctive perampanel in Indian patients aged ≥ 12 to <18 years with focal-onset seizures: Study 508
Ravat, Sangeeta
Kulkarni, Rahul
Patil, Balaji
Dash, Amitabh
Malhotra, Manoj
EPILEPSIA, 2021, 62 : 271 - 271
[35] ELEVATE Study 410 of perampanel as monotherapy or first adjunctive therapy in patients with focal-onset seizures or generalised tonic-clonic seizures: Analysis by first-line enzyme-inducing anti-seizure medication use
Klein, P.
Samad, O.
Kumar, D.
Ngo, L. Y.
Malhotra, M.
EPILEPSIA, 2022, 63 : 139 - 139
[36] Efficacy and safety of adjunctive perampanel in adolescent patients with epilepsy: Post hoc analysis of six randomized studies
Pina-Garza, J. Eric
Rosenfeld, William
Saeki, Kazunori
Villanueva, Vicente
Yoshinaga, Harumi
Patten, Anna
Williams, Betsy
Malhotra, Manoj
EPILEPSY & BEHAVIOR, 2020, 104
[37] Efficacy/safety of adjunctive perampanel for myoclonic and absence seizures: Post hoc analysis of patients aged ≥2 years in studies 332/311/232
Brandt, Christian
Ben Renfroe, J.
Ngo, Leock Y.
Patten, Anna
Malhotra, Manoj
EPILEPSIA, 2021, 62 : 41 - 41
[38] Efficacy and Safety of adjunctive Perampanel in a prospective, real-world, Phase IV study in Indian patients aged ≥12 years for Treatment of focal-onset Epilepsy: Study 508
Ravat, Sangeeta
Rohatgi, Anshu
Kulkarni, Rahul
Jabeen, Shaik A.
Patil, Balaji
Dash, Amitabh
Malhotra, Manoj
EPILEPSIA OPEN, 2024, 9 (03) : 940 - 950
[39] Efficacy and Safety of Adjunctive Perampanel for Myoclonic and Absence Seizures: Post Hoc Pooled Analysis of Adult, Adolescent, and Pediatric Patients in Studies 332, 311, and 232
Brandt, Christian
Ben Renfroe, J.
Ngo, Leock Y.
Patten, Anna
Malhotra, Manoj
NEUROLOGY, 2021, 96 (15)
[40] Efficacy and Safety of Adjunctive Perampanel for Myoclonic and Absence Seizures: Post Hoc Pooled Analysis of Adult, Adolescent, and Pediatric Patients in Studies 332, 311, and 232
Brandt, Christian
Ben Renfroe, J.
Ngo, Leock Y.
Patten, Anna
Malhotra, Manoj
ANNALS OF NEUROLOGY, 2021, 90 : S103 - S103

← 1 2 3 4 5 →